Dược Lực Học :
AZD-9684 enhances endogenous fibrinolysis.
Cơ Chế Tác Dụng :
AZD-9684 is the first member of a new anti-thrombotic class (CPU inhibitors). It is being developed by AstraZeneca.
AZD-9684 is a Carboxypeptidase U inhibitor (CPUi).
Chỉ Định :
Investigated for use/treatment in thrombosis.